Literature DB >> 7605430

Irritable bowel, irritable body, or irritable brain?

M J Farthing1.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7605430      PMCID： PMC2548562          DOI： 10.1136/bmj.310.6973.171

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  24 in total

1.  Sigmoid motility in diverticular disease and the irritable bowel syndrome.

Authors:  I F Trotman; J J Misiewicz
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

2.  Patients with irritable bowel syndrome have greater pain tolerance than normal subjects.

Authors:  I J Cook; A van Eeden; S M Collins
Journal:  Gastroenterology       Date:  1987-10       Impact factor: 22.682

3.  Towards positive diagnosis of the irritable bowel.

Authors:  A P Manning; W G Thompson; K W Heaton; A F Morris
Journal:  Br Med J       Date:  1978-09-02

4.  A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease.

Authors:  W Kruis; C Thieme; M Weinzierl; P Schüssler; J Holl; W Paulus
Journal:  Gastroenterology       Date:  1984-07       Impact factor: 22.682

5.  Non-colonic features of irritable bowel syndrome.

Authors:  P J Whorwell; M McCallum; F H Creed; C T Roberts
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

Review 6.  Controlled treatment trials in the irritable bowel syndrome: a critique.

Authors:  K B Klein
Journal:  Gastroenterology       Date:  1988-07       Impact factor: 22.682

7.  Hypnotherapy in severe irritable bowel syndrome: further experience.

Authors:  P J Whorwell; A Prior; S M Colgan
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

8.  Functional abdominal pain: further evidence that whole gut is affected.

Authors:  K J Moriarty; A M Dawson
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-05

9.  Gastrointestinal symptoms in the irritable bowel compared with peptic ulcer and inflammatory bowel disease.

Authors:  W G Thompson
Journal:  Gut       Date:  1984-10       Impact factor: 23.059

10.  Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome.

Authors:  T Poynard; S Naveau; B Mory; J C Chaput
Journal:  Aliment Pharmacol Ther       Date:  1994-10       Impact factor: 8.171
View more
  25 in total

1.  Alosetron for irritable bowel syndrome.

Authors:  Michel Lièvre
Journal:  BMJ       Date:  2002-09-14

Review 2.  Stress, oxidative injury and disease.

Authors:  Kaushal K Srivastava; Ratan Kumar
Journal:  Indian J Clin Biochem       Date:  2014-06-01

Review 3.  Treatment of irritable bowel syndrome: a review of randomised controlled trials.

Authors:  R Akehurst; E Kaltenthaler
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

4.  Actual stress, psychopathology and salivary cortisol levels in the irritable bowel syndrome (IBS).

Authors:  F R Patacchioli; L Angelucci; G Dellerba; P Monnazzi; O Leri
Journal:  J Endocrinol Invest       Date:  2001-03       Impact factor: 4.256

5.  Rectal tone and brain information processing in irritable bowel syndrome.

Authors:  S Blomhoff; S Spetalen; M B Jacobsen; M Vatn; U F Malt
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

6.  Intestinal reactivity to words with emotional content and brain information processing in irritable bowel syndrome.

Authors:  S Blomhoff; S Spetalen; M B Jacobsen; M Vatn; U F Malt
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

7.  Management of the irritable bowel syndrome. Food intolerance may play a part.

Authors:  P J Lewis
Journal:  BMJ       Date:  1995-04-22

8.  Management of the irritable bowel syndrome. Early reassurance is important part of treatment.

Authors:  R Jones
Journal:  BMJ       Date:  1995-04-22

9.  Esophageal visceral pain sensitivity: effects of TENS and correlation with manometric findings.

Authors:  M Börjesson; M Pilhall; T Eliasson; H Norssell; C Mannheimer; P Rolny
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

10.  Melatonin regulation as a possible mechanism for probiotic (VSL#3) in irritable bowel syndrome: a randomized double-blinded placebo study.

Authors:  Reuben K Wong; Cao Yang; Guang-Hui Song; Jennie Wong; Khek-Yu Ho
Journal:  Dig Dis Sci       Date:  2014-08-05       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.